医学
安慰剂
过敏
随机对照试验
摄入
鼻腔给药
内科学
临床试验
不利影响
干酪乳杆菌
免疫学
胃肠病学
皮肤病科
病理
发酵
化学
替代医学
食品科学
作者
Manabu Tamura,Takashi Shikina,Tetsuo Morihana,Masaki Hayama,Osami Kajimoto,Akane Sakamoto,Yoshitaka Kajimoto,Osamu Watanabe,C. Nonaka,Kan Shida,Masanobu Nanno
摘要
BACKGROUND: Lactobacillus casei strain Shirota (LcS) has been found to exert antiallergic effects in animal experiments, but there is little information about its clinical effects in human patients with allergy. METHODS: We performed a randomized double-blind, placebo-controlled study to investigate the effects of LcS in patients with allergic rhinitis triggered by Japanese cedar pollen (JCP). Participants were asked to drink fermented milk containing LcS (LcS group) or placebo (control group) for 8 weeks. Clinical symptoms and immunological parameters were compared between the two groups. RESULTS: Symptom-medication scores (SMS) worsened in accordance with the increase in the amount of scattered JCP. In terms of the nasal and ocular SMS, there was no significant difference between the LcS group and the placebo group during the ingestion period. In the subgroup of patients with moderate-to-severe nasal symptom scores before starting the ingestion of test samples, supplementation with LcS tended to reduce nasal SMS. CONCLUSION: These results indicate that fermented milk containing LcS does not prevent allergic symptoms in patients sensitive to JCP, but may delay the occurrence of allergic symptoms in patients with moderate-to-severe nasal symptom scores.
科研通智能强力驱动
Strongly Powered by AbleSci AI